TDG (thymine DNA glycosylase) is an essential multifunctional enzyme involved in DNA base excision repair, DNA demethylation and transcription regulation. TDG is the predominant enzyme that removes thymine from T/G mispair, which arises due to deamination of 5-methyl-cytosine at the CpG dinucleotide, thereby preventing C to T mutations. SIRT1 is a member of class III NAD + -dependent histone/protein deacetylases. In the present study, we demonstrate that SIRT1 interacts with residues 67-110 of hTDG (human TDG). In addition, SIRT1 enhances TDG glycosylase activity and deacetylates acetylated TDG. TDG acetylation weakens its interaction with SIRT1. Although acetylated TDG has reduced glycosylase activity towards T/G, 5-formylcytosine/G and 5-carboxylcytosine/G, it has a stronger activity towards a 5-fluorouracil/G substrate as compared with unmodified TDG. SIRT1 weakly stimulates acetylated hTDG activity towards T/G, 5-formylcytosine/G and 5-carboxylcytosine/G as compared with control hTDG. Sirt1-knockout mouse embryonic fibroblast cells have higher levels of TDG expression and acetylation. The physical and functional interactions between SIRT1 and TDG may mediate DNA repair, gene expression and FU (5-fluorouracil)-mediated cytotoxicity.
INTRODUCTION
The human genome is vulnerable to DNA-damaging agents of both endogenous and environmental origin. Alkylation, deamination and oxidation produce thousands of cytotoxic and mutagenic base lesions per cell per day [1] . In the absence of DNA repair, DNA damage leads to genomic instability. TDG (thymine DNA glycosylase) is a key multifunctional enzyme involved in DNA repair, gene expression and DNA demethylation (reviewed in [2] ). TDG recognizes a broad range of DNA lesions and initiates BER (base-excision repair) [2] [3] [4] [5] [6] . The major substrates of TDG are U/G and T/G which are generated by deamination. T/MeG (O 6 -methylguanine), FU (5-fluorouracil, a chemotherapeutic), 5-chlorouracil (a marker of DNA damage), 3,N 4 -ethenocytosine/G (εC/G), and oxidized bases (thymine glycol, 5-formyl-U, 5-hydroxy-U and 5-hydroxy-methyl-U) are also the substrates of TDG, suggesting a diverse role of TDG on drug sensitivity and against oxidative damage. The resulting DNA containing the AP (apurinic/apyrimidinic) site is transferred to and cleaved by APE1 (AP endonuclease I). T/G mispairs can arise through spontaneous deamination of mC (5-methylcytosine) at the CpG dinucleotide, hence their removal by TDG prevents C:G to T:A mutations. In humans, mutations at CpG sequences account for approximately 30 % of all germline mutations [7] . Importantly, mutations at CpG sites within promoter regions can alter gene expression [8] .
Another biological function of TDG is to regulate gene expression. TDG interacts with and modulates many transcription factors and transcription coactivators including the retinoic acid receptor, oestrogen receptors and p300/CBP [CREB (cAMP-response-element-binding protein)-binding protein] histone/protein acetyltransferases (reviewed in [2] ). The glycosylase activity of TDG has recently been implicated in epigenetic regulation through the process of active demethylation [9, 10] . Active DNA demethylation (reviewed in [11] ) may involve enzyme-induced mC deamination to thymine and is followed by TDG-initiated BER. Recent studies show that an alternative mechanism of DNA demethylation involves oxidation of mC to hmC (5-hydroxymethylcytosine), then to fC (5-formylcytosine), and further to caC (5-carboxylcytosine) by Tet enzymes (teneleven translocation protein, Tet1-3) [12] [13] [14] [15] . fC and caC can subsequently be excised by TDG, which leads to DNA demethylation [13, 16] . Consistent with this role, TDG is indispensible for embryonic development and TDG-defective cells contain higher levels of CpG methylation and repressive histone methylation at the promoters of developmental genes [9, 10] .
In eukaryotes, DNA repair is co-ordinated with other cellular pathways [17] . The N-terminal domain of TDG is the nexus of a variety of partner proteins including p300/CBP [18] , APE1 [18] and Hus1 [a subunit of the cell cycle sensor Rad9-Rad1-Hus1 (9-1-1) complex] [19] . The N-terminal domain of TDG binds DNA non-specifically [20] and affects T/G (but not U/G) processing [19] . It can be modified by acetylation [18] and phosphorylation [21] . Tini et al. [18] have reported that acetylation of TDG triggers the release of p300 from the DNA-TDG-p300 ternary complex and weakens its interaction with APE1. Ac-TDG (acetylated TDG) has reduced T/G glycosylase activity but has normal U/G glycosylase activity [21] . TDG acetylation/deacetylation has been proposed as a molecular switch to co-ordinate its DNA repair and transcription functions [21] . Although TDG is known to be Abbreviations used: Ac-Lys, acetyl-lysine; Ac-TDG, acetylated TDG; AP, apurinic/apyrimidinic; APE1, AP endonuclease I; BER, base-excision repair; caC, 5-carboxylcytosine; CBP, CREB (cAMP-response-element-binding protein)-binding protein; Cy5, indodicarbocyanine; fC, 5-formylcytosine; FL, fulllength; FU, 5-fluorouracil; HDAC, histone deacetylase; HEK, human embryonic kidney; hSIRT1, human SIRT1; hTDG, human TDG; mC, 5-methylcytosine; MEF, mouse embryonic fibroblast; NT, N-terminal; PARP, poly(ADP-ribose) polymerase; RT-qPCR, reverse transcription quantitative PCR; TDG, thymine DNA glycosylase. 1 Present address: Department of Natural & Physical Sciences, Life Sciences Institute, Baltimore City Community College, MD 21201, U.S.A. 2 To whom correspondence should be addressed (email aluchang@umaryland.edu).
acetylated by p300/CBP [18] , the enzyme(s) responsible for its deacetylation has not been identified thus far. HDACs (histone deacetylases) deacetylate histones and nonhistone proteins [22] . SIRTs are class III NAD + -dependent HDACs that play critical roles in cellular physiology, calorie restriction and aging (reviewed in [23, 24] ). There are seven sirtuin members in human, SIRT1-SIRT7, of which SIRT1, SIRT6 and SIRT7 are localized in the nucleus. Increasing evidence indicates that sirtuins are involved in DNA repair. SIRT1 is involved in stress response and deacetylates several proteins, including many DNA repair enzymes [25] [26] [27] [28] . In response to oxidative stress and ionizing irradiation, SIRT1 dissociates from repetitive DNA and relocalizes to DNA breaks to promote DNA repair [29] . Sirt1-knockout mice die in early postnatal stages due to altered histone modification, impaired DNA damage response and genomic instability [30, 31] .
The precise mechanism by which SIRT1 regulates genomic stability is currently under intensive investigation. The role of SIRT1 in cancer has been shown to be cell-type dependent and complex. This may be due to its diverse functions and interaction with many proteins. SIRT1 can serve as a tumour promoter or a tumour suppressor in different tissue contexts [32, 33] . In particular, SIRT1 reduction promotes tumour formation, but sanitizes cells to apoptosis by FU [34] . To study the role for SIRT1 in DNA repair, we investigated whether it has a role in the TDGmediated BER pathway. In the present study, we establish that SIRT1 affects DNA repair through binding to TDG, stimulating TDG glycosylase activity, maintaining TDG in a hypoacetylated state, and regulating TDG expression. Although Ac-TDG has reduced glycosylase activities towards T/G, fC/G and caC/G, it has a stronger activity towards FU/G substrate as compared with unmodified TDG. SIRT1 weakly stimulates acetylated hTDG (human TDG) activity toward T/G, fC/G and caC/G compared with control hTDG. Our results provide new insights into the direct role of SIRT1 in the maintenance of genomic stability.
EXPERIMENTAL

Reagents and antibodies
All reagents were obtained from Sigma-Aldrich unless otherwise stated. The antibodies used for Western blotting were anti-SIRT1 (Millipore), anti-Ac-Lys (acetyl-lysine; Calbiochem), anti-APE1 (Abcam), anti-FLAG-tag (Sigma-Aldrich), anti-β-actin (SigmaAldrich), anti-GFP (Invitrogen), HRP (horseradish peroxidase)-conjugated anti-mouse/anti-rabbit (Bio-Rad Laboratories) and anti-(rabbit IgG) DyLight 800 (Thermo Scientific) antibodies. Anti-TDG antibody for immunoprecipitation was from ABNOVA and for Western blotting was from Primo Schar (Department of Biomedicine, University of Basel, Basel, Switzerland) or generated in our own laboratory.
Polyclonal TDG antibodies against a TDG domain (residues 58-305 of hTDG) were raised in rabbits by Alpha Diagnostic International. The IgG antibodies were purified from antisera by affinity chromatography. CNBr sepharose matrices (GE Healthcare) were activated with 1 mM HCl, washed with 1 mM HCl and 0.125 M phosphate coupling buffer and then coupled with the TDG (residues 67-308) at 4
• C overnight. The coupled matrices were washed with coupling buffer and incubated with 1 M ethanolamine, pH 8.0 (blocking buffer), for 5 h at 4
• C. The matrices were washed with PBS and packed into a 10 ml column. An equal volume of PBS was added to 6 ml of antisera, filtered and loaded on to a column containing Sepharose-TDG. After washing with 40 ml of PBS, the anti-TDG antibodies were eluted with elution buffer containing 63 mM glycine, pH 2.3, and 0.2 M NaCl. Samples (0.75 ml) were collected into tubes containing 0.25 ml of neutralizing buffer (0.5 M potassium phosphate, pH 7.5). Antibody titer was performed by ELISA.
Polyclonal Ac-TDG antibodies against a peptide (residues 67-93 of hTDG with a cysteine residue at the N-terminus) containing three acetylated Lys 83 , Lys 84 and Lys 87 residues were raised in rabbits by Covance Research Products. The Ac-TDG peptide antibodies were purified similarly as described above for the TDG antibodies. The antisera were first passed through a column containing Sepharose-TDG and the flowthrough factions were then loaded on to the column containing Sepharose-Ac-TDG peptide. Antibody titre was performed by ELISA. The specificity of the Ac-TDG antibody was verified with unmodified (lane 1) and in vitro p300 acetylated hTDG (lane 2) (Supplementary Figure S1 at http://www.biochemj.org/bj/ 456/bj4560089add.htm).
Purification of SIRT1
SIRT1-FL (full-length human SIRT1) cloned in the pECE vector (clone 1791) and N-terminally truncated SIRT1 (SIRT1-NT with residues 7-83 deleted) cloned in the pCDNA3.1 vector (clone 13812) were obtained from Addgene. To express the FLAGtagged hSIRT1 (human SIRT1) proteins, the hSIRT1 constructs were transfected into HEK (human embryonic kidney)-293T cells. The cells from ten of 100 mm×20 mm tissue culture dishes were lysed with FLAG M2 lysis buffer (Sigma-Aldrich) and centrifuged at 10 000 g for 10 min. The FLAG-tagged hSIRT1 proteins were purified by FLAG M2 affinity chromatography according to the manufacturer's protocol. FLAG-SIRT1 was confirmed by SDS/PAGE and Western blotting with anti-FLAG antibody. The pooled fractions were then divided into small aliquots (10 μl) and stored at − 80
• C. The FLAG-hSIRT1-FL and FLAG-hSIRT1-NT proteins were approximately 90 % pure (Supplementary Figure S2 , lanes 2 and 3 at http://www.biochemj. org/bj/456/bj4560089add.htm) and their concentrations were determined by the Bradford method (Bio-Rad Laboratories).
Cell culture
Human HEK-293T cells were obtained from A.T.C.C. (Manassas, VA, U.S.A.). Cells were maintained at 37
• C in 5 % CO 2 in MEM (minimal essential medium; Invitrogen) supplemented with 10 % FBS and 1 % penicillin/streptomycin.
Sirt1
+ / + (wild-type) and sirt1 − / − (knockout) MEF (mouse embryonic fibroblast) cells (obtained from Dr Toren Finkel, Laboratory of Molecular Biology, National Institutes of Health, Bethesda, MD, U.S.A.) were maintained in DMEM (Dulbecco's modified Eagle's medium; Invitrogen) supplemented with 15 % FBS and 1 % penicillin/streptomycin. Cell transfection and cell extract preparation is described in the Supplementary Experimental section (at http://www.biochemj.org/bj/ 456/bj4560089add.htm).
GST pull-down assay
The pull-down assay was performed similarly to that described previously [19] . GST-fusion proteins (500 ng) were incubated with purified proteins (100 ng) in 0.2 ml of buffer G (50 mM Tris/HCl, pH 7.4, 150 mM NaCl and 2 mM EDTA) or buffer S (50 mM Tris/HCl, pH 8.0, 150 mM NaCl and 4 mM MgCl 2 ) containing 0.1 % Nonidet P40 at 4
• C with shaking overnight. After centrifugation at 1000 g for 2 min, the pellets were washed five times with 1 ml of buffer G containing 0.1 % Nonidet P40. Bound proteins were eluted by boiling in SDS loading buffer [30 mM Tris/HCl, pH 6.8, 5 % (v/v) glycerol, 1 % SDS, 0.5 mg/ml Bromophenol Blue and 1 % 2-mercapoethanol] and resolved on SDS/PAGE (10 % gels). The proteins were subsequently analysed by Western blotting using the corresponding antibodies as described above. The membranes were blocked with PBS with 0.1 % Tween 20 and 10 % (w/v) nonfat dried skimmed milk powder, reacted with primary antibodies, and then incubated with secondary antibodies with washes between each step. Western blotting was detected either using the ECL analysis system (USB Corporation, 72552) or ECL Plex (GE Healthcare) according to the manufacturer's protocols.
Co-immunoprecipitation
Cell extracts (2 mg) were precleared by adding 30 μl of Protein Gagarose (Invitrogen) for 2 h at 4
• C. After centrifugation at 1000 g, the supernatant was incubated with 4 μg of the antibody against the first protein overnight at 4
• C. Protein G-agarose (30 μl) was added and incubated for 4 h at 4
• C. After centrifugation at 1000 g, the supernatant was saved and the pellet was washed. The pellet fractions were resolved on SDS/PAGE (10 % or 12 % gels). Western blot analysis was performed with the antibody against the second protein, probed with HRP-conjugated antirabbit or anti-mouse secondary antibody, and detected by the ECL analysis system according to the manufacturer's protocol. As the heavy chain of IgG runs very close to endogenous TDG on SDS/PAGE, the Western blot analysis described above cannot be applied to examine the co-immunoprecipitation of TDG with SIRT1 antibody. Purified TDG antibody (generated in our laboratory) was labelled with Cy5 (indodicarbocyanine; GE Healthcare, PA25001) in the coupling solution (0.1 M sodium carbonate/bicarbonate, pH 9.26) according to the manufacturer's instructions. This Cy5-labelled anti-TDG antibody was then subjected to Western blot directly to detect endogenous TDG in the immunoprecipitate. The fluorescence signal was detected by Typhoon FLA 9500 (GE Healthcare).
TDG glycosylase activity assay
The DNA substrates of hTDG are a 40-mer duplex containing a T/G mismatch and 28-mer duplexes containing FU/G, fC/G or caC/G mismatch (Supplementary Table S1 at http://www. biochemj.org/bj/456/bj4560089add.htm). The strand containing the mispaired T, FU, fC or caC was labelled at the 5 end with [γ -32 P]ATP by polynucleotide kinase, annealed with the mispaired G strand as described by Lu et al. [35] . The hTDG reaction was carried out with 1.8 fmol (0.18 nM) or 50 fmol (5 nM) of DNA substrate in 10 μl reaction containing 50 mM Tris/HCl, pH 8.0, 1 mM DTT, 50 μg/ml BSA and 1 mM EDTA at 37
• C for 30 min as described previously [19] . To examine the effect of NAD + and SIRT1 on Ac-TDG, the reactions used higher concentrations of TDG and were carried out in buffer containing 50 mM Tris/HCl, pH 8.0, 1 mM DTT, 50 μg/ml BSA, 37.5 mM NaCl, 0.75 mM KCl, 1 mM MgCl 2 and various amounts of SIRT1 in the absence or presence of 3 mM NAD + . For both T/G-and FU/G-DNA, the reaction products were heated at 90
• C for 30 min in the presence of 0.1 M NaOH. For both fC/G-and caC/G-DNA, the reaction products were heated at 80
• C for 12 min in the presence of 0.1 M NaOH to avoid non-enzyme catalysed strand cleavage. The reaction samples were supplemented with 5 μl of formamide dye (90 % formamide, 10 mM EDTA, 0.1 % xylene cyanol and 0.1 % Bromophenol Blue) and 7 μl of the mixture was loaded on to a 14 % polyacrylamide sequencing gel containing 7 M urea. The gel images were detected with Image screen and viewed on a Typhoon FLA 9500 imager and quantified using ImageQuant software (GE Healthcare). The hTDG cleavage activity was calculated by the percentage of product over total DNA (product plus substrate bands). • C. Following incubation, the mixture was supplemented with 10 units of SIRT1 (Biomol), 3 mM NAD + , 150 mM NaCl, 3 mM KCl and 4 mM MgCl 2 to initiate the deacetylation reaction. The deacetylation reaction was performed with or without 10 mM nicotinamide. For SDS/PAGE analyses, after the incubation for 90 min at 37
TDG acetylation and deacetylation
• C, the reaction was terminated by adding 3× SDS sample buffer and samples were subjected to analysis on 12 % SDS/PAGE and immunoblotted with antibody against Ac-Lys or TDG to evaluate TDG acetylation. To check the glycosylase activity of Ac-TDG, the reaction solution following acetylation with p300 was passed through an Amicon Ultra 0.5 ml 10K filter (Millipore) and the buffer was exchanged to acetylation buffer without acetylCoA. The mock reaction was performed without acetyl-CoA. The amounts of mock TDG and Ac-TDG were compared by SDS/PAGE and silver stain. TDG was diluted with TDG reaction buffer and assayed as described above.
RESULTS
SIRT1 interacts with TDG
Previous studies elucidating the involvement of SIRT1 in DNA repair pathways including BER [26, 36] prompted us to investigate the link between SIRT1 and TDG. First, we examined the physical interaction between SIRT1 and TDG by GST pull-down method ( Figure 1A ). GST-TDG or a 3-fold molar excess of GST was immobilized on glutathione-Sepharose and incubated with purified FLAG-hSIRT1-FL. The pellets were fractionated on SDS/PAGE followed by Western blot analysis with the anti-FLAG antibody. hSIRT1 interacted with GST-hTDG, but not with GST ( Figure 1A , upper panel). We also showed that FLAG-hSIRT1-NT (residues 7-83 deleted) could be pulled down by GST-hTDG ( Figure 1A , lower panel). Conversely, GST-hSIRT1-NT or GST in 3-fold molar excess immobilized on glutathione-Sepharose was incubated with purified His 6 -hTDG in the pull-down assay. TDG was pulled down by immobilized GST-hSIRT1-NT protein, but not by GST ( Figure 1B) .
The interaction between SIRT1 and TDG was also demonstrated by co-immunoprecipitation. FLAG-SIRT1 and GFP-TDG were co-expressed in HEK-293T cells; the cell extract was subjected to immunoprecipitation with anti-FLAG antibody followed by Western blot analysis with anti-TDG antibody. As shown in Figure 1 (C) (upper panel), hTDG was found in the pellet with anti-FLAG antibody, but not with control IgG. Thus TDG co-precipitates with hSIRT1. Conversely, the cell extract was subjected to immunoprecipitation with anti-GFP antibody followed by Western blot analysis with anti-FLAG antibody. hSIRT1 was co-immunoprecipitated with anti-GFP antibody ( Figure 1C , lower panel). To show that endogenous SIRT1 and TDG also interact, HEK-293T cell extract was subjected to immunoprecipitation with anti-TDG antibody followed by Western blot analysis with anti-SIRT1 antibody. As shown in . Lane 1 is a negative control. Lower panel, immunoprecipation was performed with anti-SIRT1 antibody. The Western blot was detected by Cy5-labelled anti-TDG antibody which was prepared according to the manufacturer's instructions and detected by Typhoon FLA 9500 (GE Healthcare). Lane 1 is a negative control. (E) SIRT1 binds to residues 67-110 of TDG. Two TDG deletion constructs were used to determine the region within hTDG involved in binding to SIRT1. FLAG-hSIRT1-FL (100 ng) was incubated with GST-TDG constructs (as labelled) or GST alone immobilized on beads as in (A). (F) The amounts of GST and GST-TDG constructs were determined by Ponceau S stain. The same membrane of (E) was stained by Ponceau S. Owing to the large size difference, only the bands of GST-tagged proteins were shown on each lane. As indicated, GST is in an approximately 3-fold molar excess of GST-hTDG-FL, which is at a similar molar amount to GST-TDG N and GST-TDG(67-308). (G) Graphic depiction of hTDG constructs and the summary of physical interaction of these constructs with SIRT1. The intact hTDG (TDG-FL) contains 410 amino acid residues and the core catalytic domain is within residues 111-308 (shown as black boxes). The physical interactions of hTDG and SIRT1 are derived from (E). + , positive interaction; − , negative interaction.
Figure 1(D) (upper panel), SIRT1 was found in the pellet with anti-TDG antibody, but not with control IgG. Conversely, the cell extract was subjected to immunoprecipitation with anti-SIRT1 antibody followed by Western blot analysis with anti-TDG antibody. TDG1 was co-immunoprecipitated with anti-SIRT1 antibody ( Figure 1D , lower panel). These results suggest that SIRT1 and TDG associate in human cells.
To map the region of TDG that interacts with SIRT1, we constructed two GST-TDG deletion mutants. Analyses of these GST-TDG deletion constructs indicated that residues 67-110 of TDG were important for SIRT1 interaction ( Figure 1E ). Interestingly, TDG-(67-308) had a stronger interaction with SIRT1 than FL TDG ( Figure 1E , compare lane 5 with lane 3). It is also interesting to note that many regulatory factors, including CBP/p300 [18] , APE1 [18] and Hus1 [19] , also interact within the same region of the N-terminal domain of TDG.
SIRT1 enhances TDG glycosylase activity
Since hTDG physically interacts with hSIRT1, we tested whether they interact functionally. First, we used purified recombinant hTDG expressed in Escherichia coli and purified hSIRT1-FL and hSIRT1-NT expressed in HEK-293T cells to examine the effect of hSIRT1 on the hTDG glycosylase activity. When increasing amounts of hSIRT1-FL or hSIRT1-NT were added to the hTDG glycosylase reactions with DNA substrate containing a T/G mismatch, the hTDG activity was enhanced (Figures 2A and  2B , compare lane 2 with lanes 3-5). The quantification results ( Figure 2C ) showed that hSIRT1-FL and hSIRT1-NT had a similar extent of stimulation on TDG glycosylase activity on the T/G-DNA substrate. At a SIRT1/TDG ratio of 4:1, both hSIRT1-FL and hSIRT1-NT could enhance TDG activity by 6-fold. hSIRT1-FL and hSIRT1-NT alone at 2 nM did not have glycosylase or nicking activity on the T/G-DNA substrate (Figures 2A and 2B, lane 6) .
To investigate the nature of SIRT1 enhancement on TDG activity, we performed the TDG glycosylase activity assays under substrate-limiting and enzyme-limiting conditions. Under substrate-limiting conditions, the reactions contained 0.18 nM T/G-DNA, 0.5 nM TDG and 2 nM SIRT1-NT. At a SIRT1/TDG ratio of 4:1, time-course studies indicated that SIRT1 could stimulate TDG on T/G-DNA by a maximum of 6-fold ( Figures 3A-3C ). Thus SIRT1 stimulates the excision rate of TDG on T/G-DNA. In the enzyme-limiting conditions, the reactions contained 5 nM T/G-DNA, 0.5 nM TDG and 2 nM SIRT1-NT. As the AP-DNA [20, 37, 38] . Owing to this slow turnover, the TDG preparation may be only 40 % active on T/G substrate. The loss of activity in this TDG preparation may be caused by freeze-thaw.
In the presence of SIRT1, the maximum amount of DNA cleaved by TDG became higher than 1 nM, which is more than 2-fold of 0.5 nM of measured TDG concentration and more than 5-fold of 0.2 nM of active TDG concentration. Thus SIRT1 can stimulate AP-product release from TDG. From these data, we interpret that SIRT1 stimulates both the excision and turnover rates of TDG. Next, we tested whether TDG has any effect on SIRT1 deacetylase activity. An in vitro fluorescence based assay of SIRT1 deacetylase (see the Supplementary Experimental section) was performed in the presence of increasing amounts of recombinant TDG. As shown in Supplementary Figure S3 (at http://www. biochemj.org/bj/456/bj4560089add.htm), SIRT1 deacetylation activity was not affected by TDG.
SIRT1 deacetylates TDG in vitro and in vivo
TDG can be acetylated by p300/CBP [18] ; however, the enzyme(s) responsible for its deacetylation have not been identified thus far. SIRT1 has been shown to have robust deacetylation activity towards several non-histone proteins [39] , including APE1 and PARP1 [poly(ADP-ribose) polymerase 1] [25, 26] , two of the enzymes involved in BER pathway, hence it is plausible that SIRT1 may deacetylate TDG. His-tagged TDG was in vivo acetylated in HEK-293T cells, by overexpression of TDG and p300. Ac-TDG was purified and subjected to a deacetylation assay with SIRT1 and SIRT6. SIRT1 deacetylated TDG in the presence of NAD + ( Figure 4A, lane 3) . In the absence of NAD + , SIRT1 had no deacetylase activity as expected ( Figure 4A, lane 2) . Addition of nicotinamide (a SIRT1 inhibitor) abolished SIRT1 deacetylase activity on Ac-TDG ( Figure 4A,  lane 4) . SIRT6, another member of class III HDACs, also has a role in DNA repair [40] . However, SIRT6 was unable to deacetylate TDG under similar conditions (Supplementary Figure  S4 at http://www.biochemj.org/bj/456/bj4560089add.htm). In addition, recombinant TDG isolated from E. coli was acetylated in vitro with p300 in the presence of acetyl-CoA, followed by deacetylation with SIRT1. Data in Figures 4(A) and 4(B) indicate that SIRT1 can deacetylate Ac-TDG.
To test whether TDG is a target substrate of SIRT1 in human cells, we expressed GFP-TDG in HEK-293T cells with or without the co-expression of FLAG-SIRT1 or the presence of the SIRT1-specific inhibitor EX-527 [41] . TDG was immunoprecipitated by anti-GFP antibody and analysed by Western blotting with an antibody against Ac-Lys. When SIRT1 was co-expressed with GFP-TDG, the TDG acetylation level was reduced by approximately 5-fold ( Figure 4C, upper panel, compare lanes 1 and 2) . When TDGtransformed cells were treated with 10 μM of EX-527 for 48 h, the TDG acetylation level was increased by only approximately 1.5-fold ( Figure 4C, upper panel, compare lanes 1 and 3) . EX-527 increased the TDG acetylation level by approximately 6-fold in TDG and SIRT1 co-expressed cells ( Figure 4C , upper panel, compare lanes 2 and 4). The levels of GFP-TDG in the immunoprecipitants were similar ( Figure 4C, lower panel) . Thus SIRT1 deacetylates TDG both in vitro and in human cells. 
TDG acetylation weakens its interaction with SIRT1
It has been shown that mouse TDG can be acetylated by p300/CBP at four lysine residues and that acetylation of TDG weakens its interactions with p300 and APE1 [18] . The four corresponding lysine residues in hTDG are Lys 59 , Lys 83 , Lys 84 and Lys 87 . Three of these acetylated sites of hTDG (Lys 83 , Lys 84 and Lys 87 ) are within the SIRT1-binding domain. Therefore we examined the effects of TDG acetylation and NAD + on its interaction with SIRT1. We tested the pull-down reaction with GST-SIRT1 with unacetylated TDG and Ac-TDG in the SIRT1 reaction buffer (50 mM Tris/HCl, pH 8.0, 3 mM NAD + , 150 mM NaCl, 3 mM KCl and 4 mM MgCl 2 ). We found that control TDG had stronger binding with GST-SIRT1 under this condition (compare Figure 5A , lane 3 with Figure 1B , lane 3). Ac-TDG had approximately 3.7-fold reduced binding to GST-SIRT1 immobilized on beads ( Figure 5A , compare lanes 3 and 6). In the presence of NAD + in SIRT1 reaction buffer, binding of Ac-TDG to GST-SIRT1 was 2.3-fold better than that without NAD + ( Figure 5A , compare lanes 6 and 9), but is 1.6-fold weaker than the interaction between control TDG and GST-SIRT1 ( Figure 5A, compare lanes 3 and 9) . We reasoned that in the presence of NAD + , Ac-TDG was deacetylated by SIRT1, but the deacetylation reaction was not complete.
Figure 5 Effect of acetylation on TDG interaction with SIRT1
(A) Ac-TDG has a reduced physical interaction with hSIRT1. hTDG was acetylated in vitro by p300 (lanes 4-9) and control TDG was treated similarly but without acetyl-CoA (lanes 1-3). GST alone (lanes 2, 5 and 8) and GST-hSIRT1 (lanes 3, 6 and 9) were immobilized on glutathione-Sepharose and incubated with 100 ng TDG in buffer S (50 mM Tris/HCl, pH 8.0, 150 mM NaCl and 4 mM MgCl 2 ). Lane 1, 10 ng His 6 -tagged TDG (5 % of input); lane 2, unacetylated control TDG bound to GST alone; and lane 3, control TDG bound to GST-SIRT1-FL immobilized on beads. Lanes 4-6 are similar to lanes 1-3, except using in vitro Ac-TDG. Lanes 7-9 are similar to lanes 4-6, except adding 3 mM NAD + in the incubation buffer. Western blot was probed with a primary anti-TDG antibody made in our laboratory and anti-(rabbit IgG) DyLight 800 (Thermo Scientific) secondary antibody. The image was detected by Typhoon 
Acetylation alters DNA glycosylase activity and subtracts specificity of TDG
It has been shown that Ac-TDG has reduced T/G glycosylase activity, but has normal U/G glycosylase activity [21] . We confirmed that acetylated hTDG had 2.5-fold decreased T/G glycosylase activity ( Figure 6A , compare lanes 2 with 6). Acetylated hTDG could still be enhanced by SIRT1, but at reduced levels as compared with control TDG ( Figure 6A , compare lanes 2-5 with lanes 6-9). The TDG deacetylation by SIRT1 requires the NAD + cofactor. Thus we examined whether NAD + has any effect on SIRT1 stimulation of TDG activity. We observed that TDG glycosylase activity was much weaker in SIRT1 reaction buffer (results not shown). Thus, to examine the effect of NAD + and SIRT1 on Ac-TDG, TDG glycosylase reactions were supplemented with 3 mM NAD + , 37.5 mM NaCl, 0.75 mM KCl, 1 mM MgCl 2 and various amounts of SIRT1. Under this condition, at SIRT1/TDG ratios of 4:1 and 8:1, hSIRT1-FL could enhance TDG activity by 11-and 26-fold respectively ( Figure 5C , compare lanes 4 and 5 with lane 2). Similar to the results in Figure 6 (A), acetylated hTDG had 2.5-fold decreased T/G glycosylase activity ( Figure 5C , compare lanes 2 with 7) and was hardly enhanced by SIRT1 ( Figure 5C , compare lanes 2-5 with lanes 7-10). In the presence of NAD + , Ac-TDG had 2-fold increased T/G glycosylase activity ( Figure 5C , compare lanes 7 with 12) and was enhanced by SIRT1 ( Figure 5C, lanes 12-15) at similar levels as control TDG and at a much higher level than in the absence of NAD + ( Figure 5D ). At SIRT1/TDG ratios of 4 and 8, hSIRT1-FL could enhance TDG activity by 9-and 25-fold respectively ( Figure 5C, compare lanes 14 and 15 with lane 12) . We suggest that, in the presence of NAD + , Ac-TDG is deacetylated by SIRT1 and has activity similar to control TDG. With unacetylated TDG, NAD + did not have an effect (neither stimulation nor inhibition) on SIRT1 enhancement of T/G excision activity (Supplementary Figure S5 at http://www.biochemj.org/bj/456/ bj4560089add.htm). FU, a chemotherapeutic drug commonly used in cancer treatment, inhibits thymidylate synthase, imbalances nucleotide pools, thereby favouring misincorporation of uracil and FU into genomic DNA. It has been shown that FU/G is a substrate of TDG and that TDG mediates the DNA-directed cytotoxic effect of FU [3, 5, 10] . We thus tested whether Ac-TDG had an altered activity to FU/G-containing DNA. Surprisingly, Ac-TDG had a 6-fold stronger activity towards FU/G substrate as compared with unmodified TDG (Figure 6B, compare lanes 2 and 6) . Acetylated hTDG could be enhanced by SIRT1 at increased levels as compared with control TDG (Figure 6B , compare lanes 2-5 with lanes 6-9). At a SIRT1/TDG ratio of 4:1, hSIRT1-FL could enhance the activities of control TDG and Ac-TDG on FU/G-DNA substrate by 2-and 4.5-fold respectively. SIRT1 alone at 0.8 nM did not have glycosylase or nicking activity on the FU/G-DNA substrate ( Figure 6B, lane 10) .
Recent studies show that the role of TDG in DNA demethylation may involve removing fC and caC [13, 16] . Thus we checked the effects of TDG acetylation on its glycosylase activity on fC/G and caC/G substrates. As fC and caC are labile in the presence of 0.1 M NaOH at 90
• C, the glycosylase reactions were heated at 80
• C for 12 min to observe AP products, but to avoid non-enzyme catalysed strand cleavage at fC and caC. Under this condition, the AP site is not completely processed by β/δ-elimination, thus two cleavage products were observed: the upper one is derived by β-elimination only and the lower one is produced by β/δ-elimination. Unmodified TDG had activity on fC/G-and caC/G-substrates ( Figures 6C and 6D , lane 2) as reported [13, 16] . Ac-TDG had approximately 5-fold weaker activities towards these substrates as compared with unmodified TDG (Figures 6C and 6D, compare lanes 2 and 6) . SIRT1 stimulated the glycosylase activity towards fC/G of unmodified TDG, but not of Ac-TDG ( Figure 6C) . On caC/G, SIRT1 exerted 2.5-fold higher enhancements on unmodified TDG than on Ac-TDG ( Figure 6D , compare lanes 3-5 with lane 2 and compare lanes 7-9 with lane 6). SIRT1 alone did not have glycosylase or nicking activity on these two DNA substrates ( Figure 6C and 6D, lane 10). These results suggest that deacetylation and stimulation of the TDG activity by SIRT1 will enhance DNA demethylation.
SIRT1 influences TDG expression
SIRTs act as gene silencers by deacetylating histones (reviewed in [23, 24] ). To determine whether the TDG expression level is regulated by SIRT1, we monitored TDG protein levels in total cell extracts prepared from wild-type and sirt1-knockout MEFs by Western blotting ( Figure 7A ). The level of TDG protein increased by approximately 3-fold in sirt1-knockout cells as normalized to the amounts of β-actin ( Figure 7A ). In contrast, the APE1 protein level was nearly unchanged. To determine the acetylation level of TDG in sirt1-knockout MEFs, we developed anti-Ac-TDG-specific antibodies against a peptide (residues 67-93 of hTDG) containing three acetylated Lys 83 , Lys 84 and Lys 87 residues. The specificity of the anti-Ac-TDG antibody was verified with unmodified (lane 1) and in vitro p300 acetylated hTDG (lane 2) (Supplementary Figure S1) . Consistent with the finding of Figure 4 that TDG is deacetylated by SIRT1, a Western blot with anti-Ac-TDG-specific antibodies showed a preferentially reactive band in sirt1-knockout cell extracts as compared with control extracts ( Figure 7A, middle panel) . To determine whether the increased TDG protein level in sirt1-knockout cells is controlled at the transcription level, we examined the Tdg mRNA level. As shown in Figure 7 (B), analysis by RTqPCR (reverse transcription quantitative PCR) indicated that the Tdg mRNA level in sirt1-knockout cells was 1.9 + − 0.2-fold of that of the wild-type cells using the mRNA of β-actin as an internal control. Thus, the level of Tdg mRNA is up-regulated in sirt1-knockout cells.
DISCUSSION
Mammalian sirtuins play vital role in many biological processes, such as insulin secretion, fat mobilization, response to stress and lifespan regulation (reviewed in [23, 24] ). SIRT1 exerts multiple functions through regulation of different targets, including histones and many non-histone proteins [32] . It has been shown that SIRT1 is involved in DNA repair [28, 31, 36, 42] . SIRT1-defective or knockdown cells have been shown to be more sensitive to UV light, MMS (methyl methanesulfonate), H 2 O 2 , ionizing irradiation and FU [26, 28, 31, 34, [42] [43] [44] .
SIRT1 can deacetylate three enzymes involved in the BER pathway: TDG (Figure 4 ), APE1 [26] and PARP1 [25] . In the case of PARP, SIRT1-dependent deacetylation blocks its activity and protects cells from PARP1-mediated cell death [25] . In addition, SIRT1 suppresses PARP1 gene expression. Interestingly, both PARP1 and SIRT1 activities are dependent on NAD + . In contrast, SIRT1 does not regulate APE1 gene expression ( Figure 7A ) and deacetylation of APE1 by SIRT1 does not affect APE1 activity in vitro [26] . However, deacetylation of APE1 promotes its binding to XRCC1 (X-ray cross-complementing-1), thus stimulating DNA repair activity in vivo [26] . In the present study, we demonstrate that SIRT1 modulates the BER pathway by enhancing TDG glycosylase activity, deacetylating TDG and suppressing TDG gene expression. Hence SIRT1 is a key regulator of the BER.
The N-terminal domain of TDG is required for SIRT1 interaction. This region also interacts with many other protein partners, including p300/CBP [18] , APE1 [18] and the 9-1-1 complex [19] . It will be valuable to know how TDG uses the same domain to select its partners and how to regulate these interactions. The interaction of TDG with SIRT1 results in modest stimulation of hTDG glycosylase activity towards T/G, FU/G, fC/G and caC/G mismatches. It will be interesting to test SIRT1 effects on TDG activity with other DNA substrates [2] [3] [4] [5] [6] . Because TDG has a protective role against oxidative damage, the SIRT1-mediated stimulation may play an important role in the balance between accumulation of oxidative DNA damage and its repair.
The physical and functional interactions between SIRT1 and TDG are altered by TDG acetylation. TDG acetylation weakens its physical interaction with SIRT1. The T/G glycosylase activity of unacetylated TDG was increased by 6-fold in TDG reaction buffer ( Figure 2 ) and by 11-fold in the presence of a 4-fold molar excess of SIRT1 in quarter strength of SIRT1 reaction buffer ( Figures 5C and 5D ). Ac-TDG has reduced glycosylase activity towards T/G, fC/G, and caC/G, but it has a stronger activity towards FU/G substrate as compared with unmodified TDG (Figure 6 ). Such a regulatory network of protein interaction and protein acetylation/deacetylation allows TDG to function in DNA repair and transcription [21] . Thus unacetylated TDG is the preferred form for DNA repair and DNA demethylation whereas Ac-TDG enhances FU sensitivity (Figure 8 ). We propose that SIRT1 has two interactions with TDG: its deacetylase activity acts on Ac-TDG and it stimulates the T/G glycosylase activity of the resulting unacetylated TDG. Given that SIRT1 can both bind and deacetylate TDG, TDG deacetylation by SIRT1 may suffer from minor product inhibition. Although the mechanism for these interactions is unclear, the product inhibition has been observed in many DNA glycosylases including TDG [38] .
The anticancer effect of FU, one of the widely used anticancer agents, is thought to involve multiple pathways [45] . This includes the incorporation of U and FU into DNA followed by their excision by a DNA glycosylase, leading to DNA fragmentation and cell death [45] . Consistent with a role for TDG in this process, Kunz et al. [46] have shown that inactivation of TDG significantly SIRT1 enhances TDG glycosylase activity, deacetylates TDG and suppresses TDG gene expression. Ac-TDG has reduced glycosylase activities towards T/G, fC/G, and caC/G mismatches, but has a stronger activity towards FU/G substrate as compared with unmodified TDG. Thus we propose that unmodified TDG is responsible for DNA repair of T/G mismatches and DNA demethylation, whereas Ac-TDG promotes FU removal. If the resulting AP sites are not efficiently repaired by BER after FU removal, spontaneous breakage at AP sites leads to the persistence of single-strand DNA lesions. During DNA replication, these DNA nicks can be converted into double-strand breaks. Alternatively, spontaneous breakage at nearby AP sites generates double-strand breaks and thus causes FU cytotoxicity and cell death.
increases cellular resistance towards FU. This probably reflects TDG activity against FU/G lesions because its FU/A activity is relatively weak [6] . It has been shown that down-regulation of SIRT1 increase cellular sensitivity to FU [34, 43] . However, the molecular mechanism for SIRT1's effect on protecting cells from apoptosis upon FU treatment has not been investigated. We hypothesize that the physical and functional interactions between SIRT1 and TDG may mediate FU cytotoxicity ( Figure 8 ). As Ac-TDG has 6-fold higher activity towards FU/G substrate as compared with unmodified TDG ( Figure 6B , compare lanes 2 with 6), TDG glycosylase activity on FU/G mismatches may increase in sirt1-knockout cells in which TDG is overproduced and hyperacetylated.
TDG also functions in DNA demethylation and gene regulation [9, 10, 13, 14, 16, [47] [48] [49] [50] . Interaction between TDG and SIRT1 may co-ordinate DNA methylation with histone acetylation. It has been shown that CpG methylation is associated with histone hypoacetylation and epigenetic silencing [51] . SIRT1 maintains TDG in the hypoacetylated form which has higher glycosylase activity towards T/G, fC/G and caC/G mismatches. Moreover, SIRT1 exerted higher enhancement on unmodified TDG than on Ac-TDG on these DNA substrates. Both of these SIRT1 actions are crucial for TDG's function in active DNA demethylation [9, 10] . This suggests that SIRT1 may act as a gene activator, contradicting its usual role as a gene silencer. Thus we hypothesize that SIRT1 has dual roles and may be dependent on its interaction with TDG -SIRT1 deacetylates histones and induces compact chromatin at silenced genes; however, it deacetylates and enhances TDG at active genes. The dual roles of SIRT1 are in agreement with the observations that SIRT1 has oncogenic properties, but, paradoxically, can act as a tumour suppressor in different cell types [32, 33] . These apparent pleiotropic effects of SIRT1 may be due to its diverse functions and interactions with many proteins, one of which would be TDG. 
SUPPLEMENTARY ONLINE
EXPERIMENTAL Plasmids
Full-length and truncated cDNA of TDG cloned in plasmids pET28 and pGEX-4T-2 vectors has been described previously [1] . Full-length TDG (residues 1-410) and truncated hTDG constructs containing TDG-N-(111-410) and TDG-(67-308) cloned in pGEX-4T-2 vector (GE Healthcare) were transformed into BL21 Star cells (Stratagene) to express GST-tagged proteins. pET28-TDG-FL was transformed into Rosetta E. coli cells to produce His-tagged full-length TDG protein.
To express GFP-tagged hTDG in human cells, human TDG cDNA was amplified by PCR using template pET28-TDG-FL and the primers listed in Table S1 . The PCR product was digested with SacI and BamH1 and ligated with digested pEGFP-N1 (Clonetech) to yield pEGFP-TDG. To express His 6 -tagged TDG in human cells, human TDG cDNA was cut out from pET28-TDG-FL by digestion with BamH1 and XbaI and ligated with digested pcDNA3.1 (Invitrogen) to yield pcDNA3-TDG. Full-length human SIRT1 (SIRT1-FL) in pECE vector and Nterminal truncated SIRT1 (SIRT1-NT with residues 7-83 deleted) cloned in pcDNA3.1 vector were obtained from Addgene. SIRT1 cDNA was amplified by PCR using template SIRT1-NT and the primers listed in Table S1 . The PCR product was digested with BamH1 and XhoI and ligated into the digested pGEX-4T-2 (GE Healthcare) to yield pGEX-SIRT1-NT. Plasmid pCIN4-p300 was obtained from Dr Jianyuan Luo (Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, U.S.A.).
Cell transfection and cell extract preparation
For immunoprecipitation, HEK-293T cells (5×10 6 cell/10-cmdiameter dishes) were cotransfected with GFP-hTDG and FLAG-SIRT1 plasmids (5 μg of each) using FuGENE HD (Invitrogen) according to the manufacturer's instructions and allowed to grow for 72 h. Cells were harvested, washed with PBS, and lysed by using 1 ml of lysis buffer [50 mM Tris/HCl, pH 7.4, 50 mM NaCl, 1 mM EDTA, 1 % Triton X-100 and 10 μl of protease inhibitor cocktail (P8340, Sigma-Aldrich)] per 10-cm-diameter dish containing 10 6 -10 7 cells. The whole-cell extracts were quickly frozen using liquid nitrogen and stored at − 80
• C. The protein concentration was determined by the Bradford method (Bio-Rad Laboratories).
To isolate acetylated TDG from human cells, His 6 -hTDG and p300 plasmids were transiently transfected into HEK-293T cells. Cell extracts were prepared as above and acetylated TDG was purified using a nickel column (Qiagen). The majority of Ac-TDG was found in the flow-through fraction which was then aliquoted (10 μl) and stored at − 80
• C. To investigate in vivo TDG deacetylation, the GFP-hTDG plasmid (5 μg) was transiently transfected into HEK-293T cells in the absence or presence of SIRT1-FL plasmid (5 μg) as above. The SIRT1-specific inhibitor EX-527 (1 μM) (Tocris Bioscience) [2] was added 6 h before cell harvest. Equal amounts of cell extracts were subjected to immunoprecipitation by anti-GFP antibody (Abcam) and the Western blot was probed with an antiAc-Lys antibody (Calbiochem).
Detection of TDG mRNA level by RT-qPCR
Total RNA from MEFs was isolated by the RNeasy kit method (Qiagen). RNA (100 ng) was used as a template for RT-qPCR reactions using primers for hTDG and actin (Table S1 ). Real-time PCR was performed using the Light Cycler 480 II Detection System (Roche) with iScript TM SYBR ® Green One-Step kit (Bio-Rad Laboratories). The reactions were carried out with one initial step for RT at 50
• C for 10 min followed by PCR cycles (95
• C for 30 s, 60
• C for 30 s and 70
• C for 45 s). The mRNA level of Tdg was calculated relative to that of actin as C T , which is the difference between the number of cycles required to go above background in Tdg and actin samples. The fold difference of Tdg mRNA levels of wild-type cells over Sirt1 KO (knockout) cells was calculated according to the formula 2 C T (KO)− C T (WT) . The reactions were carried out in duplicate and data are averaged from three independent experiments. SIRT1 decetylase activity assay SIRT1 decetylase activity was determined with the SIRT1 Direct Fluorescent Screening Assay kit (Cayman Chemical) according to the manufacturer's instructions. The reaction was set up with 30 nM SIRT1 in deactylase buffer containing 50 mM Tris/HCl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2 and 3 mM NAD + . The deacetylation reaction was initiated by adding 125 μM substrate which is a p53 peptide Arg-His-LysLys(e-acetyl)-AMC (7-amino-4-methoxy coumarin). After 45-min incubation at room temperature (23 • C), 50 μl of developing solution was added for additional 30 min at room temperature. The fluorophore was analysed using excitation wavelength of 350-360 nm and emission wavelength of 450-465 nm in fluorescence spectrophotometer Cary Eclipse. Increasing amounts of TDG (15, 30 and 60 nM) were added to investigate the influence of TDG on SIRT1 deacetylase activity. Reactions without enzyme or with 30 nM TDG were used as negative controls. 
